Turku PET Centre, University of Turku, Turku, Finland.
Department of Cardiology, Leiden University Medical Center, Leiden, the Netherlands.
JACC Cardiovasc Imaging. 2017 Nov;10(11):1361-1370. doi: 10.1016/j.jcmg.2016.10.025. Epub 2017 May 17.
The purpose of this study was to evaluate the prognostic value of sequential hybrid imaging strategy in which positron emission tomography (PET) perfusion imaging is performed selectively in patients with suspected obstructive coronary artery disease (CAD) on coronary computed tomography angiography (CTA).
Coronary CTA is an accurate diagnostic test for excluding obstructive CAD. However, the positive predictive value is suboptimal.
We investigated 864 consecutive symptomatic patients with intermediate probability of CAD who adhered to the sequential imaging approach. PET myocardial perfusion imaging using O-labeled water during adenosine stress was performed when suspected obstructive stenosis was present on coronary CTA. The major adverse events (AEs) including all-cause mortality, myocardial infarction (MI), and unstable angina pectoris (UAP) were recorded.
During a median follow-up of 3.6 years, 16 deaths, 10 MIs, and 5 UAPs occurred. Obstructive CAD was excluded by coronary CTA in 462 (53%) patients who had significantly lower annual AE rate than did patients with suspected obstructive stenosis on coronary CTA (0.4% vs. 1.5%; p = 0.003). The latter underwent PET study, on which 195 (49%) had normal and 207 had abnormal perfusion. The annual rate of AEs was 5 times higher in those with abnormal perfusion than with normal perfusion (2.5% vs. 0.5%; p = 0.004). Patients with normal perfusion had AE rate comparable to patients without obstructive CAD on coronary CTA (p = 0.77).
In patients with suspected CAD obstructive disease can be excluded in 53% of patients by coronary CTA, and these patients have good outcome. About one-half (49%) of the remaining patients have normal perfusion and event rate comparable to patients without obstructive CAD on coronary CTA while patients with ischemia have clearly worse outcome. Sequential approach utilizing anatomical imaging by coronary CTA followed by selective functional perfusion imaging is a feasible strategy to diagnose and risk-stratify patients with suspected CAD.
本研究旨在评估正电子发射断层扫描(PET)灌注成像在冠状动脉计算机断层扫描血管造影(CTA)检查怀疑有阻塞性冠状动脉疾病(CAD)患者中的序贯混合成像策略的预后价值。
冠状动脉 CTA 是一种准确的排除阻塞性 CAD 的诊断试验。然而,阳性预测值并不理想。
我们调查了 864 例连续的有中度 CAD 可能性的症状性患者,这些患者遵循序贯成像方法。当冠状动脉 CTA 显示疑似阻塞性狭窄时,使用 O-标记的水进行腺苷应激 PET 心肌灌注成像。记录主要不良事件(AE),包括全因死亡率、心肌梗死(MI)和不稳定型心绞痛(UAP)。
在中位随访 3.6 年期间,有 16 例死亡、10 例 MI 和 5 例 UAP。462 例(53%)患者通过冠状动脉 CTA 排除了阻塞性 CAD,他们的年 AE 发生率明显低于冠状动脉 CTA 有疑似阻塞性狭窄的患者(0.4%比 1.5%;p=0.003)。后者进行了 PET 研究,其中 195 例(49%)有正常灌注,207 例有异常灌注。异常灌注患者的年 AE 发生率是正常灌注患者的 5 倍(2.5%比 0.5%;p=0.004)。正常灌注患者的 AE 发生率与冠状动脉 CTA 无阻塞性 CAD 的患者相似(p=0.77)。
在疑似 CAD 的患者中,冠状动脉 CTA 可排除 53%的患者有阻塞性疾病,这些患者的预后良好。其余约一半(49%)患者的灌注正常,与冠状动脉 CTA 无阻塞性 CAD 的患者的事件发生率相似,而有缺血的患者的预后明显更差。利用冠状动脉 CTA 进行解剖成像,然后选择性进行功能灌注成像的序贯方法是诊断和风险分层疑似 CAD 患者的可行策略。